2026 Q2 Portfolio Activity
In 2026 Q2, SECTOR GAMMA AS maintained a portfolio of 49 distinct positions. The most significant new addition was THERMO FISHER SCIENTIFIC INC, now representing 3.65% of the total fund value. They heavily accumulated shares in IQVIA HLDGS INC, increasing the position by 93.7%. Conversely, SECTOR GAMMA AS completely exited their position in UNITEDHEALTH GROUP INC.
Position History
hover any row below to update
Loading…
Total Positions
49
Quarter
2026 Q2
Top Holding
BMY (9.1%)
Top 10 Concentration
48.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-49 of 49
SECTOR GAMMA AS Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BMY
BRISTOL-MYERS S...
|
Healthcare | 9.08% | 11.86% |
#1
Prev: #1
|
6.1 |
—
|
-101,786 | -12.3% |
P
S
|
726,115 | $41,838,746 | 2009 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
MRK
MERCK & CO INC
|
Healthcare | 6.05% | 7.39% |
#2
Prev: #2
|
4.4 |
—
|
-43,332 | -16.6% |
P
S
|
217,008 | $27,885,528 | 2011 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
MDT
MEDTRONIC PLC
|
Healthcare | 5.98% | 5.74% |
#3
1
Prev: #4
|
5.9 |
—
|
71,755 | 25.6% |
P
S
|
352,437 | $27,571,147 | 2009 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
PFE
PFIZER INC
|
Healthcare | 5.25% | 7.24% |
#4
1
Prev: #3
|
3.1 |
—
|
-87,170 | -8.0% |
P
S
|
1,004,215 | $24,181,497 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
INCY
INCYTE CORP
|
Healthcare | 4.20% | 4.46% |
#5
Prev: #5
|
2.7 |
—
|
-29,757 | -14.8% |
P
S
|
170,753 | $19,356,560 | 2011 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
ELV
ELEVANCE HEALTH...
|
Healthcare | 3.73% | 3.04% |
#6
5
Prev: #11
|
2.0 |
—
|
537 | 1.2% |
P
S
|
44,499 | $17,209,098 | 2016 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 3.66% | 3.20% |
#7
2
Prev: #9
|
4.0 |
—
|
55,000 | 22.9% |
P
S
|
294,918 | $16,875,208 | 2009 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
TMO
THERMO FISHER S...
|
Healthcare | 3.65% | — |
#8
Prev: #—
|
5.0 |
—
|
33,584 | — |
NEW
|
33,584 | $16,837,674 | 2009 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
CVS
CVS HEALTH CORP
|
Healthcare | 3.49% | 2.30% |
#9
6
Prev: #15
|
3.4 |
—
|
20,000 | 14.8% |
P
S
|
155,337 | $16,069,613 | 2009 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
IQV
IQVIA HLDGS INC
|
Healthcare | 3.27% | 1.62% |
#10
11
Prev: #21
|
4.3 |
—
|
37,714 | 93.7% |
P
S
|
77,944 | $15,060,340 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 3.26% | 3.00% |
#11
1
Prev: #12
|
3.3 |
—
|
20,000 | 11.8% |
P
S
|
189,468 | $15,022,918 | 2017 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
BDX
BECTON DICKINSO...
|
Healthcare | 3.06% | 3.07% |
#12
2
Prev: #10
|
3.2 |
—
|
10,553 | 12.8% |
P
S
|
93,168 | $14,099,113 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
ABT
ABBOTT LABS
|
Healthcare | 2.90% | 2.12% |
#13
5
Prev: #18
|
4.2 |
—
|
59,912 | 68.4% |
P
S
|
147,444 | $13,379,069 | 2009 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
GEHC
GE HEALTHCARE T...
|
Healthcare | 2.89% | 2.12% |
#14
3
Prev: #17
|
4.2 |
—
|
81,445 | 64.4% |
P
S
|
207,863 | $13,305,311 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
ZBH
ZIMMER BIOMET H...
|
Healthcare | 2.66% | 3.33% |
#15
7
Prev: #8
|
1.6 |
—
|
-13,528 | -8.7% |
P
S
|
142,307 | $12,251,210 | 2009 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
BIIB
BIOGEN INC
|
Healthcare | 2.54% | 3.90% |
#16
9
Prev: #7
|
1.0 |
—
|
-35,933 | -39.9% |
P
S
|
54,163 | $11,702,458 | 2009 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
N/A
QIAGEN NV
|
|
Unknown | 2.44% | 1.54% |
#17
7
Prev: #24
|
4.0 |
—
|
125,269 | 77.1% |
P
S
|
287,640 | $11,246,724 | — | 13F Filing | 2026-06-30 | 2026-08-12 | ||
|
CNC
CENTENE CORP DE...
|
Healthcare | 2.26% | 1.26% |
#18
8
Prev: #26
|
1.9 |
—
|
no change | no change |
P
S
|
162,405 | $10,424,777 | 2012 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
REGN
REGENERON PHARM...
|
Healthcare | 2.13% | — |
#19
Prev: #—
|
4.4 |
—
|
15,780 | — |
NEW
|
15,780 | $9,839,461 | 2018 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
BIO
BIO RAD LABS IN...
|
Healthcare | 2.12% | 1.56% |
#20
3
Prev: #23
|
3.3 |
—
|
9,600 | 40.4% |
P
S
|
33,350 | $9,791,894 | 2013 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
CAH
CARDINAL HEALTH...
|
Healthcare | 2.10% | 2.74% |
#21
8
Prev: #13
|
0.8 |
—
|
-14,208 | -25.9% |
P
S
|
40,689 | $9,666,079 | 2009 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
AMGN
AMGEN INC
|
Healthcare | 2.06% | 3.92% |
#22
16
Prev: #6
|
0.8 |
—
|
-20,874 | -44.3% |
P
S
|
26,281 | $9,516,876 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
BRKR
BRUKER CORP
|
Healthcare | 1.99% | 2.17% |
#23
7
Prev: #16
|
0.8 |
—
|
-101,658 | -40.0% |
P
S
|
152,352 | $9,168,543 | 2019 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
AVTR
AVANTOR INC
|
Healthcare | 1.95% | 1.29% |
#24
1
Prev: #25
|
3.3 |
—
|
210,685 | 30.3% |
P
S
|
906,088 | $8,970,271 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
PTCT
PTC THERAPEUTIC...
|
Healthcare | 1.77% | 1.21% |
#25
3
Prev: #28
|
3.2 |
—
|
25,000 | 33.3% |
P
S
|
100,000 | $8,157,000 | 2019 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
LH
LABCORP HOLDING...
|
Healthcare | 1.58% | 1.20% |
#26
3
Prev: #29
|
3.1 |
—
|
7,000 | 36.8% |
P
S
|
26,019 | $7,285,320 | 2009 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
DXCM
DEXCOM INC
|
Healthcare | 1.49% | 0.83% |
#27
5
Prev: #32
|
3.6 |
—
|
46,000 | 82.0% |
P
S
|
102,122 | $6,877,917 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
N/A
ASCENDIS PHARMA...
|
|
Unknown | 1.23% | — |
#28
Prev: #—
|
4.0 |
—
|
21,305 | — |
NEW
|
21,305 | $5,682,470 | — | 13F Filing | 2026-06-30 | 2026-08-12 | ||
|
EW
EDWARDS LIFESCI...
|
Healthcare | 1.19% | 1.14% |
#29
2
Prev: #31
|
1.5 |
—
|
no change | no change |
P
S
|
60,402 | $5,463,965 | 2013 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 1.15% | 1.58% |
#30
8
Prev: #22
|
1.0 |
—
|
-44,268 | -15.5% |
P
S
|
241,739 | $5,284,415 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 1.12% | — |
#31
Prev: #—
|
3.9 |
—
|
121,128 | — |
NEW
|
121,128 | $5,169,743 | 2009 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
KURA
KURA ONCOLOGY I...
|
Healthcare | 1.03% | 0.79% |
#32
2
Prev: #34
|
2.4 |
—
|
21,202 | 5.1% |
P
S
|
433,012 | $4,750,142 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 0.99% | — |
#33
Prev: #—
|
3.9 |
—
|
80,000 | — |
NEW
|
80,000 | $4,544,800 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
CRNX
CRINETICS PHARM...
|
Healthcare | 0.93% | 0.81% |
#34
1
Prev: #33
|
2.9 |
—
|
20,433 | 21.7% |
P
S
|
114,628 | $4,289,380 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
TNDM
TANDEM DIABETES...
|
Healthcare | 0.87% | 1.21% |
#35
8
Prev: #27
|
1.3 |
—
|
no change | no change |
P
S
|
267,091 | $4,030,403 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
IOVA
IOVANCE BIOTHER...
|
Healthcare | 0.87% | 0.75% |
#36
1
Prev: #37
|
2.3 |
—
|
68,466 | 7.6% |
P
S
|
968,466 | $4,028,819 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 0.83% | — |
#37
Prev: #—
|
3.8 |
—
|
45,000 | — |
NEW
|
45,000 | $3,833,550 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
OGN
ORGANON & CO
|
Healthcare | 0.80% | 0.53% |
#38
3
Prev: #41
|
0.3 |
—
|
-105,193 | -28.0% |
P
S
|
270,781 | $3,666,375 | 2021 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
ARDX
ARDELYX INC
|
Healthcare | 0.76% | 0.73% |
#39
Prev: #39
|
2.8 |
—
|
170,713 | 33.1% |
P
S
|
686,844 | $3,502,904 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
NTLA
INTELLIA THERAP...
|
Healthcare | 0.68% | — |
#40
Prev: #—
|
3.8 |
—
|
185,177 | — |
NEW
|
185,177 | $3,133,195 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 0.00% | 0.44% |
Sold All 😨
(Was: #42) |
0.0 |
—
|
-30,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 0.00% | 0.73% |
Sold All 😨
(Was: #40) |
0.0 |
—
|
-80,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
DNLI
DENALI THERAPEU...
|
Healthcare | 0.00% | 0.74% |
Sold All 😨
(Was: #38) |
0.0 |
—
|
-162,710 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 0.00% | 0.78% |
Sold All 😨
(Was: #36) |
0.0 |
—
|
-44,263 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
HUM
HUMANA INC
|
Healthcare | 0.00% | 0.79% |
Sold All 😨
(Was: #35) |
0.0 |
—
|
-19,202 | -100.0% |
CLOSED
|
— | $— | 2012 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 0.00% | 1.15% |
Sold All 😨
(Was: #30) |
0.0 |
—
|
-21,305 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
LNTH
LANTHEUS HLDGS ...
|
Healthcare | 0.00% | 1.67% |
Sold All 😨
(Was: #20) |
0.0 |
—
|
-93,344 | -100.0% |
CLOSED
|
— | $— | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
GILD
GILEAD SCIENCES...
|
Healthcare | 0.00% | 1.75% |
Sold All 😨
(Was: #19) |
0.0 |
—
|
-53,247 | -100.0% |
CLOSED
|
— | $— | 2016 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
UNH
UNITEDHEALTH GR...
|
Healthcare | 0.00% | 2.33% |
Sold All 😨
(Was: #14) |
0.0 |
—
|
-36,435 | -100.0% |
CLOSED
|
— | $— | 2009 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 |
Showing 1-49 of 49 holdings